Summary
This review summarizes the eosinophil’s affector and effector mechanisms, emphasizes their biochemical aspects, and details their function in certain immunologic and parasitic conditions.
References
Ackerman S. J., Loegering D. A., Gleich G. J.: Human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay — J. Immunol.125, 2118, 1980.
Andersen V., Bro-Rasmussen F., Ilougaard K.: Autoradiographic studies of eosinophil kinetics: effects of cortisol — Cell Tiss. Kinet.2, 139, 1969.
Archer G. T., Air G., Jackas M., Morell D. B.: Studies on rat eosinophil peroxidase — Biochim. biophys. Acta (Amst.)99, 96, 1965.
Archer G. T., Hirsch J. G.: Isolation of granules from eosinophil leukocytes and study of their enzyme content — J. exp. Med.18, 277, 1963.
Archer R. K., Broome J.: Studies on the peroxidase reaction of living eosinophils and other leukocytes — Acta haemat. (Basel)29, 147, 1963.
Arnoldsson H., Helander E.: Some aspects on the problem of eosinophilia errors in method, diurnal rhythm, and eosinophilia in allergy — Acta allerg. (Kbh.)12, 96, 1958.
Bass D. A.: Behavior of eosinophil leukocytes in acute inflammation. I. Lack of dependence on adrenal function — J. clin. Invest.55, 1229, 1975.
Bass D. A.: Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation — J. clin. Invest.56, 870, 1975.
Basten A., Beeson P. B.: Mechanism of eosinophilia. II. Role of the lymphocyte — J. exp. Med.131, 1288, 1970.
Basten A., Boyer M. H., Beeson P. B.: Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats toTrichinella spiralis — J. exp. Med.131, 1271, 1970.
Beeson P. B., Bass D. A.: The eosinophil — W. B. Saunders, Philadelphia, 1977.
Boswell R. N., Austen K. F., Goetzl E. G.: Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demonstration of structural heterogeneity — J. Immunol.120, 15, 1978.
Bujak J. S., Root R. K.: The role of peroxidase in the bacterial activity of human blood eosinophils — Blood43, 727, 1974.
Butterworth A. E., David J. R.: Eosinophil function — New Engl. J. Med.304, 154, 1980.
Butterworth A. E., David J. R., Franks D., Mahmoud A. A. F., David R. H., Sturrock R. F., Houba V.: Antibody-dependent eosinophil-mediated damage to51Cr-labelled schistosomula ofSchistosoma mansoni: damage by purified eosinophils — J. exp. Med.145, 136, 1977.
Butterworth A. E., Sturrock R. F., Houba V., Mahmoud A. A. F., Sher A., Rees P. H.: Eosinophils as mediators of antibody-dependent damage to schistosomula — Nature (Lond.)256, 727, 1975.
Butterworth A. E., Wassom D. L., Gleich G. J., Loegering D. A., David J. R.: Damage to schistosomula ofSchistosoma mansoni induced directly by eosinophil major basic protein — J. Immunol.122, 221, 1979.
Capron A., Dessaint J.-P., Joseph M., Rousseaux R., Capron M., Bazin H.: Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation — Europ. J. Immunol.7, 315, 1977.
Charcot J. M., Robin C.: Observations de leucocythémie — C.R. Mém. Soc. Biol. (Paris)5, 44, 1853.
Clark R. A. F., Gallin J. I., Kaplan A. P.: The selective eosinophil chemotactic activity of histamine — J. exp. Med.142, 1462, 1975.
Colley D. G.: Eosinophils and immune mechanisms. I. Eosinophil stimulation promotor (ESP): a lymphokine induced by specific antigen or phytohemagglutinin — J. Immunol.110, 1419, 1973.
Colley D. G.: Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promotor — Cell. Immunol.24, 328, 1976.
Colley D. G.: Lymphocyte products. In:Mahmoud A. A. F., Austen K. F. (Eds): The eosinophil in health and disease. Grune and Stratton, New York, 1980; p. 293.
Collins E. J., Aschenbrenner J., Nakahama M.: Biologic action of betamethasone 17,21-dipropionate in rat and dog — Steroids20, 543, 1972.
Connell J. T.: Abnormal eosinophils, eosinophilia and basophilia in methimazole — Ann. Allergy27, 595, 1969.
Cunningham A. S.: Eosinophil counts: age and sex differences — J. Pediat.87, 426, 1975.
Dancey J. T., Deubelbeiss K. A., Harker L. A., Finch C. A.: Neutrophil kinetics in man — J. clin. Invest.58, 705, 1976.
Dean D. A., Wistar R., Murrell K. D.: Combinedin vitro effects of rat antibody and neutrophilic leukocytes on schistosomula ofSchistosoma mansoni — Amer. J. trop. Med. Hyg.23, 420, 1974.
de Chatelet L. R., Migler R. A., Shirley P. S., Muss H. B., Szejda P., Bass D. A.: Comparison of intracellular bactericidal activities of human neutrophils and eosinophils — Blood52, 609, 1978.
Deubelbeiss K. A.: Kinetik der neutrophilen Granulozyten — Schweiz. med. Wschr.105, 1168, 1975.
Discombe G.: Criteria of eosinophilia — Lanceti, 195, 1946.
Donohue D. M., Gabrio B. W., Finch C. A.: Quantitative measurement of hemopoietic cells of the marrow — J. clin. Invest.37, 1564, 1958.
Donohue D. M., Reiff R. H., Hanson M. L., Betson Y., Finch C. A.: Quantitative measurement of the erythrocytic and granulocytic cells of the marrow and blood — J. clin. Invest.37, 1571, 1958.
Ehrlich P.: Beiträge zur Kenntnis der granulierten Bindegewebezellen und der eosinophilen Leukozyten — Arch. Anat. Physiol. (Physiol. Abt.) 1879; p. 166.
Essellier A. F., Wagner K. F.: Über den Wirkungsmechanismus des ACTH auf das eosinophile Zell-system — Acta haemat. (Basel)8, 63, 1952.
Felarca A. B., Lowell F. C.: The total eosinophil count in a nonatopic population — J. Allergy40, 16, 1967.
Fernandez H. N., Henson P. M., Otani A., Hugli T. E.: Chemotactic response to C3a and C5a. I. Evaluation of C3a and C5a leukotaxisin vitro and under simulatedin vivo conditions — J. Immunol.120, 109, 1978.
Fine D. P., Buchanan R. D., Colley D. G.:Schistosoma mansoni infection in mice depleted of thymusdependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation — Amer. J. Path.71, 193, 1973.
Foot E. C.: Eosinophil turnover in the rat — Nature (Lond.)198, 297, 1963.
Frigas E., Loegering D. A., Gleich G. J.: Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium — Lab. Invest.42, 35, 1980.
Gilman P. A., Jackson D. P., Guild H. G.: Congenital agranulocytosis: prolonged survival and terminal acute leukemia — Blood36, 576, 1970.
Glauert A. M., Butterworth A. E., Sturrock R. G., Houba V.: The mechanism of antibody-dependent, eosinophil-mediated damage to schistosomula ofSchistosoma mansoni in vitro: a study by phase-contrast and electron microscopy — J. Cell Sci.34, 173, 1978.
Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D.: Cytotoxic properties of the eosinophil major basic protein — J. Immunol.123, 2925, 1979.
Gleich G. J., Loegering D. A., Kueppers F., Bajaj S. P., Mann K. G.: Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules — J. exp. Med.140, 313, 1974.
Gleich G. J., Loegering D. A., Maldonado J. E.: Identification of a major basic protein in guinea pig eosinophil granules — J. exp. Med.137, 1459, 1973.
Gleich G. J., Loegering D. A., Mann K. G., Maldonado J. E.: Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils — J. clin. Invest.57, 633, 1976.
Godlowski Z. Z.: Prevention of hormonal eosinopenia and lymphopenia by inhibition of clotting in blood — Brit. med. J.i, 854, 1951.
Goetzl E. J., Austen K. F.: Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis — Proc. nat. Acad. Sci. (Wash.)72, 4123, 1975.
Goetzl E. J., Austen K. F.: Factors regulating eosinophil migration in immediate hypersensitivity reactions. In:Mandel T. E., Cheers C., Hosking C. S., McKenzie I. F. C., Nossal G. J. V. (Eds): Progress in immunology III. Australian Acad. Sci., Canberra, 1977; p. 439.
Goetzl E. J., Gorman R. R.: Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil leukocytes by 12-L-OH-5,8,10-heptadecatrienoic acid (HHT) — J. Immunol.120, 526, 1978.
Goetzl E. J., Tashjian A. H. Jr.,Rubin R. R., Austen K. F.: Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinoma of human lung — J. clin. Invest.61, 770, 1978.
Goetzl E. J., Weller P. F., Sun F. F.: The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETES) — J. Immunol.124, 926, 1980.
Goetzl E. J., Weller P. F., Valone F. H.: Biochemical and functional bases of the regulatory and protective roles of the human eosinophil. In:Weissmann G., Samuelsson B., Paoletti R. (Eds): Advances in immunology. Raven Press, New York, 1979; p. 157.
Goetzl E. J., Woods J. M., Gorman R. R.: Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) — J. clin. Invest.59, 170, 1977.
Gorham S. D., Cantz M.: Arylsulfatase B, an exosulfatase for chondroitin-4-sulfate tetrasaccharide — Hoppe-Seylers Z. physiol. Chem.359, 1811, 1978.
Greene B. M., Colley D. G.: Eosinophils and immune mechanisms. III. Production of the lymphokine eosinophil stimulation promotor by mouse T lymphocytes — J. Immunol.116, 1078, 1976.
Gross R.: The eosinophils. In:Braunsteiner H., Zucker-Franklin D. (Eds): The physiology and pathology of leukocytes. Grune and Stratton, New York, 1962; p. 1.
Grove D. I., Mahmoud A. A. F., Warren K. S.: Eosinophils and resistance toTrichinella spiralis — J. exp. Med.145, 755, 1977.
Hammarström S., Murphy R. C., Samuelsson B., Clark D. A., Mioskowski C., Corey E. J.: Structure of leukotriene C. Identification of the amino acid part — Biochem. biophys. Res. Commun.91, 1266, 1979.
Hardy W. R., Anderson R. E.: The hypereosinophilic syndromes — Ann. intern. Med.68, 1220, 1968.
Hills A. G., Forsham P. H., Finch C. A.: Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotropic hormone (ACTH) in man — Blood3, 755, 1948.
Horn B. R., Robin E. D., Theodore J., van Kessel A.: Total eosinophil counts in the management of bronchial asthma — New Engl. J. Med.292, 1152, 1975.
Hudson G.: Quantitative study of the eosinophil granulocytes — Semin. Hemat.5, 166, 1968.
Jacobson B. S.: Isolation of plasma membrane from eukaryotic cells on polylysine-coated polyacrylamide beads — Biochim. biophys. Acta (Amst.)471, 331, 1977.
Jacobson B. S., Branton D.: Plasma membrane: rapid isolation and exposure of the cytoplasmic surface by use of positively charged beads — Science195, 302, 1977.
James S. L., Colley D. G.: Eosinophil-mediated destruction ofSchistosoma mansoni eggs — J. reticuloendothel. Soc.20, 359, 1977.
James S. L., Colley D. G.: Eosinophil-mediated destruction ofSchistosoma mansoni eggsin vitro. II. The role of cytophilic antibody — Cell. Immunol.38, 35, 1978.
Janeway C. A., Jr.,Jason J. M.: How T lymphocytes recognize antigens — CRC crit. Rev. Immunol.1, 133, 1980.
Johnson G. R., Dresch C., Metcalf D.: Heterogeneity in human neutrophil, macrophage and eosinophil progenitor cells demonstrated by velocity sedimentation separation — Blood50, 823, 1977.
Johnson G. R., Nicholas W. L., Metcalf D., McKenzie I. F. C., Mitchell G. F.: Peritoneal cell population of mice infected withMesocestoides corti as a source of eosinophils — Int. Arch. Allergy59, 315, 1979.
Kater L. A., Goetzl E. J., Austen K. F.: Isolation of human eosinophil phospholipase D — J. clin. Invest.57, 1173, 1976.
Kay A. B.: The role of the eosinophil — J. Allergy clin. Immunol.64, 90, 1979.
Kay A. B., Anwar A. R. E.: Eosinophil surface receptors. In:Mahmoud A. A. F., Austen K. F. (Eds): The eosinophil in health and disease. Grune and Stratton, New York, 1980; p. 207.
Kay A. B., Austen K. F.: The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung — J. Immunol.107, 899, 1971.
Kay A. B., Pepper D. S., McKenzie R.: The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen — Brit. J. Haemat.27, 669, 1974.
Kay A. B., Stechschulte D. J., Austen K. F.: An eosinophil leukocyte chemotactic factor of anaphylaxis — J. exp. Med.133, 602, 1971.
Kazura J. W., Grove D. I.: Stage-specific antibody-dependent eosinophil-mediated destruction ofTrichinella spiralis — Nature (Lond.)274, 588, 1978.
Killmann S. A., Cronkite E. P., Fliedner T. M., Bond V. P.: Mitotic indices of human bone marrow cells. III. Duration of some phases of erythrocytic and granulocytic proliferation computed from mitotic indices — Blood24, 267, 1964.
Lachmann P. J., Kay A. B., Thompson R. A.: The chemotactic activity for neutrophil and eosinophil leukocytes of the trimolecular complex of the fifth, sixth, and seventh components of human complement\((C\overline {567} )\) prepared in free solution by the ‘reactive lysis’ procedure — Immunology19, 895, 1970.
Lehrer R. I., Cline M. J.: Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance toCandida infection — J. clin. Invest.48, 1478, 1969.
Lewis D. M., Lewis J. C., Loegering D. A., Gleich G. J.: Localization of the guinea pig eosinophilic major basic protein to the core of the granule — J. Cell Biol.77, 702, 1978.
Leyden E.: Zur Kenntnis des Bronchial-Asthma — Virchows Arch. path. Anat.54, 324, 1872.
Mackenzie C. D., Ramalho-Pinto F. J., McLaren D. J., Smithers S. R.: Antibody-mediated adherence of rat eosinophils to schistosomula ofSchistosoma mansoni in vitro — Clin. exp. Immunol.30, 97, 1977.
Mahmoud A. A. F.: Eosinopoiesis. In:Mahmoud A. A. F., Austen K. F. (Eds): The eosinophil in health and disease. Grune and Stratton, New York, 1980; p. 61.
Mahmoud A. A. F., Austen K. F. (Eds): The eosinophil in health and disease. Grune and Stratton, New York, 1980.
Mahmoud A. A. F., Stone M. K., Kellermeyer R. W.: Eosinophilopoietin: a low molecular weight peptide stimulating eosinophil production in mice — Trans. Ass. Amer. Phycns91, 127, 1978.
Mahmoud A. A. F., Warren K. S., Graham R. C. Jr.: Anti-eosinophil serum and the kinetics of eosinophilia in schistosomiasismansoni — J. exp. Med.142, 560, 1975.
Mahmoud A. A. F., Warren K. S., Peters P. A.: A role for the eosinophil in acquired resistance toSchistosoma mansoni infection as determined by anti-eosinophil serum — J. exp. Med.142, 805, 1975.
McGarry M. P., Miller A. M.: Evidence for the humoral stimulation of eosinophil granulocytopoiesis inin vivo diffusion chambers — Exp. Hemat.2, 372, 1974.
McGarry M. P., Speirs R. S., Jenkins V. K., Trentin J. J.: Lymphoid cell dependence of eosinophil response to antigen — J. exp. Med.134, 801, 1971.
McKenzie I. F. C., Potter T.: Murine lymphocyte surface antigens — Advanc. Immunol.27, 179, 1979.
Migler R., de Chatelet L. R.: Human eosinophilic peroxidase: biochemical characterization — Biochem. Med.19, 16, 1978.
Migler R., de Chatelet L. R., Bass D. A.: Human eosinophilic peroxidase: role in bactericidal activity — Blood51, 445, 1978.
Miller A. M., McGarry M. P.: A diffusible stimulator of eosinophilopoiesis produced by lymphoid cells as demonstrated with diffusion chambers — Blood48, 293, 1976.
Mitchell G.: Responses to infection with metazoan and protozoan parasites in mice — Advanc. Immunol.28, 451, 1979.
Murphy R. C., Hammarström S., Samuelsson B.: Leukotriene C: a slow-reacting substance from murine mastocytoma cells — Proc. nat. Acad. Sci. (Wash.)76, 4275, 1979.
Ohnishi H., Kosuzume H., Kitamura Y., Yamaguchi K., Nobuhara M., Suzuki Y., Yoshida S., Tomioka H., Kumagai A.: Structure of slow-reacting substance of anaphylaxis (SRS-A) — Prostaglandins20, 655, 1980.
Otteson E. A., Cohen S. G.: The eosinophil, eosinophilia, and eosinophil-related disorders. In:Middleton E. Jr.,Reed C. E., Ellis E. F. (Eds): Allergy: principles and practice. C.V. Mosby, St. Louis, 1978; vol. II, p. 584.
Panzenhagen H., Speirs R. S.: Effect of horse serum, adrenal hormones and histamine on the number of eosinophils in blood and peritoneal fluid of mice — Blood8, 536, 1953.
Parker C. W., Koch D. A., Huber M. M.: Arylsulfatase inactivation of slow-reacting substance. Evidence for proteolysis as a major mechanism when ordinary commercial preparations of the enzyme are used — Prostaglandins20, 887, 1980.
Parwaresch M. R., Walle A. J., Arndt D.: The peripheral kinetics of human radiolabelled eosinophils — Virchows Arch. Abt. B21, 57, 1976.
Ponzio N. M., Speirs R. S.: Lymphoid cell dependence of eosinophil response to antigen. III. Comparison of the rate of appearance of two types of memory cells in various lymphoid tissues at different times after priming — J. Immunol.110, 1363, 1973.
Ponzio N. M., Speirs R. S.: Lymphoid cell dependence of eosinophil response to antigen. V. Evidence for the induction of separate memory cells mediating cellular and humoral responses to tetanus toxoid — Z. Immun.-Forsch.146, 405, 1974.
Ponzio N. M., Speirs R. S.: Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid — Immunology28, 243, 1975.
Presently B., Szapiro L.: Hereditary deficiency of peroxidase and phospholipids in eosinophilic granulocytes — Acta haemat. (Basel)41, 359, 1969.
Ramalho-Pinto F. J., McLaren D. J., Smither S. R.: Complement-mediated killing of schistosomula ofSchistosoma mansoni by rat eosinophilsin vitro — J. exp. Med.147, 147, 1978.
Rebhun J.: Eosinophils and the integrity of the hypothalamic-pituitary-adrenal axis — Ann. Allergy36, 86, 1976.
Rud F.: The eosinophil count in health and mental disease: biometrical study — Acta Psychiat. (Kbh.)40 (Suppl.), 1, 1947.
Rytömaa T.: Organ distribution and histochemical properties of eosinophil granules in the rat — Acta path. microbiol. scand.50 (Suppl. 140), 12, 1960.
Sabag N., Castrillón M. A., Tchernitchin A.: Cortisol-induced migration of eosinophil leukocytes to lymphoid organs — Experientia (Basel)34, 666, 1978.
Salmon S. E., Cline M. J., Schultz J., Lehrer R. I.: Myeloperoxidase deficiency: immunologic study of a genetic leukocyte defect — New Engl. J. Med.282, 250, 1970.
Sjogren U.: Low mitotic activity in eosinophilic leukemia — Acta haemat. (Basel)55, 153, 1976.
Smith J. A., Goetzl E. J.: Cellular properties of eosinophils: regulatory, protective and potentially pathogenetic roles in inflammatory states. In:Weissmann G. (Ed.): The cell biology of inflammation. Elsevier/North-Holland, Amsterdam, 1980; p. 189.
Speirs R. S., Gallagher M. T., Rauschwerger J., Heim L. R., Trentin J. J.: Lymphoid cell dependence of eosinophil response to antigen. II. Location of memory cells and their dependence upon thymic influence — Exp. Hemat.1, 150, 1973.
Srivastava R. K., Bhasin V., Srivastava V. K., Tayal G., Prasad D. N.: A study on characterization of adrenoreceptors mediating eosinopenia in rabbits — Indian J. med. Res.65, 402, 1977.
Stryckmans P. A., Cronkite E. P., Greenberg M. L., Schiffer L. M.: Kinetics of eosinophil proliferation in man — Proc. 12th Congr. Int. Soc. Hemat., New York, 1968; F19.
Teir H., Rytömaa T., Cederberg A., Kiviniemi K.: Studies on the elimination of granulocytes in the intestinal tract in rat — Acta path. microbiol. scand.59, 311, 1963.
Thorn G. W., Gorsham P. H., Prunty F. T. C., Hills A. G.: A test for adrenal cortical insufficiency — J. Amer. Med. Ass.137, 1005, 1948.
Vadas M. A., David J. R., Butterworth A., Pisani N. T., Siongok T. A.: A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula ofSchistosoma mansoni — J. Immunol.122, 1228, 1979.
Valone F. H., Goetzl E. J.: Immunological release in the rat peritoneal cavity of lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes — J. Immunol.120, 102, 1978.
Venge P., Dahl R., Hällgren R., Olsson I.: Cationic proteins of human eosinophils and their role in the inflammatory reaction. In:Mahmoud A. A. F., Austen K. F.: The eosinophil in health and disease. Grune and Stratton, New York, 1980; p. 131.
Walls R. S.: Lymphocytes and specificity of eosinophilia — S. Afr. med. J.50, 1313, 1976.
Walls R. S., Basten A., Leuchars E., Davies A. J. S.: Mechanisms for eosinophilic and neutrophilic leucocytosis — Brit. med. J.iii, 157, 1971.
Walls R. S., Hersey P., Quie P. G.: Macrophage-eosinophil interactions in the inflammatory response toTrichinella spiralis — Blood44, 131, 1974.
Wasserman S. I., Goetzl E. J., Austen K. F.: Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase — J. Immunol.114, 645, 1975.
Wasserman S. I., Goetzl E. J., Ellman L., Austen K. F.: Tumor-associated eosinophilotactic factor — New Engl. J. Med.290, 420, 1974.
Wassom D. L., Gleich G. J.: Damage toTrichinella spiralis newborn larvae by eosinophil major basic protein — Amer. J. trop. Med. Hyg.28, 860, 1979.
Weller P. F., Goetzl E. J.: The regulatory and effector roles of eosinophils — Advanc. Immunol.27, 339, 1979.
Weller P. F., Goetzl E. J.: The human eosinophil: roles in host defense and tissue injury — Amer. J. Path.100, 793, 1980.
Weller P. F., Goetzl E. J., Austen K. F.: Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals — Proc. nat. Acad. Sci. (Wash.)77, 7440, 1980.
Weller P. F., Lewis R. A., Corey E. J., Austen K. F.: The interaction of purified human eosinophil arylsulfatase B with synthetic leukotrienes — Fed. Proc.40, 1023, 1981.
Weller P. F., Wasserman S. I., Austen K. F.: Selected enzymes preferentially present in the eosinophil. In:Mahmoud A. A. F., Austen K. F. (Eds): The eosinophil in health and disease. Grune and Stratton, New York, 1980; p. 115.
West B. C., Gelb N. A., Rosenthal A. S.: Isolation and partial characterization of human eosinophil granules: comparison to neutrophils — Amer. J. Path.81, 575, 1975.
Wharton-Jones T.: The blood corpuscle considered in its different phases of development in the animal series. Memoir I. Vertebrata — Phil. Trans. B163, 63, 1846.
Yoffey J. M., Bhurgan R. K.: Myeloid metaplasia in the cervical lymph gland of the normal guinea pig — J. Anat. (Lond.)98, 681, 1964.
Zeiger R. S., Yurdin D. L., Colten H. R.: Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase, and histamine methyl transferase in human leukocytes — J. Allergy clin. Immunol.58, 172, 1976.
Zilversmit D. B., Hughes M. E.: Phospholipid exchange between membranes. In:Korn E. D. (Ed.): Methods in membrane biology. Plenum Press, New York, 1976; vol. 7, p. 211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, J.A. Molecular and cellular properties of eosinophils. La Ricerca Clin. Lab. 11, 181–193 (1981). https://doi.org/10.1007/BF02890524
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02890524
Key-words
- Arylsulfatase B
- Biological properties
- Cationic proteins
- Charcot-Leyden crystals
- Chemical properties
- Chemotaxis
- Complement receptors
- Eosinophils
- Eosinopoiesis
- Helminthic infections
- Histaminase
- Immediate hypersensitivity
- Lysophospholipase
- Major basic protein
- Peroxidase
- Phospholipase D
- Phospholipid exchange protein
- Slow reacting substance of anaphylaxis